Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib + Joins in Knee Osteoarthritis
NCT04718649Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Randomised, double-blind trial in osteoarthritis (OA) comparing Celebrex + Joins with Celebrex + Placebo (2 arms). Primary endpoint: Western Ontario and McMaster University Arthritis Index Pain Scale at 36 weeks. Status: unknown.
02
Drugs
JOINS
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04718649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04718649.